Ocular GVHD: Eye Problems After BMT

Ocular GVHD (Graft-Versus-Host Disease) is an immune-mediated condition that develops after a bone marrow or stem cell transplant. Donor immune cells attack the tear glands and eye surface, causing dry eyes, burning, redness, and light sensitivity. Early specialist evaluation and treatment protect the eye surface and preserve vision long-term.


Ocular GVHD affects your eyes after a bone marrow or stem cell transplant. Donor immune cells target your tear glands and corneal surface. The condition can appear weeks, months, or even years after transplant. Early identification changes outcomes significantly.

This condition sits at the intersection of haematology and ophthalmology. Your transplant team and your eye doctor need to work together. Regular eye review is part of post-transplant care, not an optional extra.


What Is Ocular GVHD?

Graft-Versus-Host Disease (GVHD) is an immune-mediated inflammatory reaction. It occurs when donor immune cells recognise the recipient’s tissues as foreign and attack them. Several organs can be affected, including the skin, liver, gut, and eyes.

The eye is more commonly affected in chronic GVHD, but acute GVHD can also involve the ocular surface. When the eyes are involved, the condition is called Ocular GVHD.


What Are the Symptoms of Ocular GVHD?

Symptoms range from mild to severe. They include one or more of the following:

  • Dry eyes and a persistent gritty sensation
  • Burning and irritation
  • Redness
  • Excessive watering and tearing
  • Light sensitivity
  • Blurred or fluctuating vision

In children, obvious complaints are often absent. Parents may notice excessive eye rubbing, light sensitivity, or reluctance to open the eyes in bright light.

Do not dismiss vague symptoms such as discomfort, scratchiness, or eye fatigue. These can be early signs of ocular GVHD. Your transplant surgeon may request an eye evaluation even when you have no symptoms at all.


How Is Ocular GVHD Diagnosed?

A complete eye examination is the starting point. This includes visual acuity testing, refraction, slit-lamp examination, and tear film assessment.

Your eye doctor will also perform specific tests to evaluate the ocular surface. These include the Schirmer’s test, and staining of the cornea with fluorescein and/or Rose Bengal dyes. These tests assess tear production and identify surface damage not visible to the naked eye.


How Is Ocular GVHD Treated?

Management focuses on controlling dryness, reducing inflammation, preventing infection, and protecting the cornea from scarring.

Systemic drugs given by your bone marrow transplant team for the rest of the body often do not adequately treat the eyes. Your eye doctor will likely recommend one or more of the following:

  • Lubricating eye drops to improve comfort and reduce corneal damage
  • Steroid eye drops to control inflammation and prevent scarring
  • Antibiotic eye drops to prevent or treat secondary infection
  • Autologous serum eye drops to support healing of the ocular surface
  • Cyclosporine eye drops to reduce the immune-mediated reaction

Treatment is adjusted over time based on disease activity and symptom burden. This is a condition that needs long-term follow-up, not a single course of treatment.


How is Ocular GVHD Classified?

Acute ocular GVHD develops during or soon after systemic acute GVHD and is characterized by sudden inflammation, redness, pain, tearing, photophobia, and conjunctival involvement.

Chronic ocular GVHD is a long-term immune-mediated disease that typically presents with persistent dry eye, burning, grittiness, fluctuating vision, meibomian gland dysfunction, and progressive ocular surface damage.

Acute-on-chronic ocular GVHD occurs when a patient with established chronic ocular GVHD experiences a sudden inflammatory flare, causing a rapid worsening of symptoms such as redness, pain, light sensitivity, and ocular surface inflammation on top of their baseline chronic dry eye disease.


Who Is Most at Risk?

Anyone who has undergone a bone marrow or stem cell transplant can develop ocular GVHD. Risk is higher in:

  • Patients with chronic GVHD affecting other organs
  • Patients on prolonged immunosuppression
  • Those with a history of acute GVHD

Children who have had transplants are a particularly vulnerable group. Symptoms may be subtle. Eye problems can quietly affect reading, school performance, and daily comfort without an obvious complaint from the child.


When to See a Specialist

See an eye specialist promptly if any of the following apply.

You or your child has had a bone marrow or stem cell transplant, and eye symptoms have appeared at any point after — not only in the early weeks.

Symptoms are present but mild. Mild ocular GVHD does not stay mild without treatment. Surface damage accumulates quietly.

Your transplant team has not yet arranged an ophthalmic review. Ask for one. It should be part of standard post-transplant follow-up.

Vision feels “off” even though a recent check showed normal acuity. Tear film instability affects functional vision. Standard acuity testing does not capture it.

You have been given lubricants but the symptoms persist. This is a signal for specialist evaluation, not a reason to try a different brand of drops.

What Doctors Sometimes Miss

Ocular GVHD is underdiagnosed. Several patterns come up repeatedly in practice.

Symptoms labelled as “just dry eyes.” Post-transplant dryness is not routine dry eye. The mechanism is different, the severity is higher, and the risk of corneal scarring is real. It needs specialist evaluation, not over-the-counter drops.

Children who don’t complain. A child who rubs their eyes, squints, or avoids reading is not always being difficult. These are ocular surface symptoms. Parents and transplant teams both need to watch for them.

The quiet chronic phase. Acute GVHD gets attention. Chronic ocular GVHD can smoulder for months with low-grade symptoms. Vision may remain measurably normal while the surface continues to deteriorate. Symptom absence does not mean the eye is safe.

Delayed referral from transplant teams. Eye review is sometimes requested only after symptoms become severe. Baseline ophthalmic evaluation before or shortly after transplant is better practice. Earlier review means earlier intervention.


Ocular GVHD: Symptoms, Causes, and When to Worry

SymptomWhat It MeansWhen to Worry
Dryness and grittinessTear gland damage from donor immune cellsIf persistent or worsening despite lubricants
Burning and irritationOcular surface inflammationIf affecting daily activities, reading, or sleep
RednessConjunctival involvementIf sudden, severe, or accompanied by pain
Light sensitivityCorneal surface damageIf debilitating or new after a settled period
Blurred or fluctuating visionTear film instability or corneal changesAlways warrants prompt specialist review
Eye rubbing in childrenMay be the only visible signIf post-transplant, refer early — do not wait
Watering and tearingReflex response to surface drynessIf combined with other symptoms

FAQs

Can ocular GVHD occur without dry eye symptoms?

Yes. Some patients present with redness, light sensitivity, or blurred vision rather than classic dryness. In children, the only sign may be eye rubbing or reluctance to be in bright light. A specialist examination is more reliable than symptom-based self-assessment.

Does ocular GVHD go away on its own?

Occasionally it settles with time, but many patients need long-term treatment. Stopping treatment early often leads to flare-ups. Your eye doctor will guide when and how to taper any medications.

Can both eyes be affected?

Yes. Ocular GVHD typically affects both eyes, though one side may be more symptomatic than the other.

Is teleconsultation available for ocular GVHD follow-up?

Yes. If you live outside Gurgaon or are unable to travel, teleconsultation is available to support ongoing management in partnership with your local eye doctor.


This page is part of the Dry Eye Disease hub. Read about our full approach to GVHD, dry eyes, and children’s eye care. Please also read the Pediatric Eye Care hub.

Here’s another heartening patient story: A young boy and his love for trucks, and Chronic GVHD and Success Stories.


About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google

Read a patient story:

Ocular GVHD in Children

Chronic GVHD and Success Stories

Can Ocular GVHD Cause Dry Eyes?

Ocular GVHD is an eye condition that can develop after bone marrow or stem cell transplant, causing dry eyes, irritation, and fluctuating vision even after the main illness stabilises. Long-term follow-up helps protect the ocular surface, support daily function, and prevent slow, quiet damage from becoming permanent.

Here’s the story of a young girl’s grit and determination, as she battle GVHD. She is now a DOCTOR herself!!


She Came Back Every Holiday

A clinical story about ocular GVHD, dry eyes, and what it means to stay

Some patients stay in your memory because the diagnosis was rare.

Others stay because you realise, years later, that you were not just treating a condition. You were quietly watching somebody become who they were going to be.

I first met her when she was fifteen or sixteen. She had already been through more than most adults carry in a lifetime. She had undergone a bone marrow transplant. And afterwards, she developed ocular graft-versus-host disease — ocular GVHD.

Families who arrive after transplantation carry a particular kind of relief. The worst has happened. Treatment happened. Something enormous has been crossed. But uncertainty travels with them, because the body does not always stop at the finish line of the illness that was treated.

Then the eyes become part of the story.


What Ocular GVHD Feels Like From the Inside

Most people imagine ocular GVHD as something visibly dramatic. Sometimes it is. But for many patients, it arrives quietly.

Dryness that feels like something is always wrong, even on a good day. Burning that begins before the rest of the body feels tired. Vision that stays technically normal but no longer feels effortless.

Reading that becomes work. Studying that becomes slower. Screen time that was once easy and now costs something.

She was fifteen. She was trying to get back to school. She was trying to become a teenager again, the way teenagers are supposed to be — carelessly occupied with the future. And every day, her eyes made that harder.


Managing Ocular GVHD: What Actually Helps

Over the months that followed, we worked through treatment together. We managed her ocular surface carefully. We adjusted care as her symptoms changed. The active ocular GVHD gradually settled. Her vision got better. The comfort improved. Her reading improved. She got back to school.

But as so often happens with ocular GVHD, the story did not simply end when the acute phase resolved. She continued to have dry eyes. Frequent inflammation, sudden flare ups. Good months and difficult ones. The kind of low-grade, persistent vulnerability that does not make headlines but shapes ordinary days.

Steroids, in varying strengths, and frequency; lubricating eyedrops. Her BMT specialist and I, spoke about her thrice a day on some days, and some times, not even once a month.

She lived in Lucknow. Not nearby. And yet she kept coming back. Every few months. Then every holiday. Keeping in touch over the phone. Sometimes, just to talk. And we kept titrating her treatment to her symptoms, and to the disease activity.

Not because something dramatic was happening. Not because her vision was deteriorating. She came because follow-up had quietly become part of how she looked after herself. She understood, at sixteen, what many adults take years to learn: that a condition managed well is a condition you stop noticing.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google


What Patients Actually Remember

Doctors tend to think patients remember the treatment.

Patients usually remember something else. They remember whether someone recognised them the next time they walked in. They remember not having to explain everything from the beginning. They remember the quality of continuity more than the quality of any single intervention.

She sat her Class 12 examinations. Then she prepared for medical entrance exams.

One day she came to see me with her parents. Her eyes were stable. Her vision was good. She had come not because she needed treatment, but because she had received a medical school offer and wanted advice.

Which college. Which city. Whether to go far from home. We sat and talked. Years earlier we had been discussing tear films and corneal staining and drop regimens. Now we were discussing hostels and futures and what she wanted her life to look like.

She chose South India. She started medical school. Her parents were apprehensive because it was far away. Dr Shibal, she said, you can take care of me long distance, can’t you? I gave her a hug.

Your medical college will have an eye doctor, love. Yes, she said, but they’ll not be you.

And she still comes back. Every six months. Every holiday.

At one visit, she smiled and said something I still think about.

My vision is pristine.

I had to pause with that for a moment.

Because I do not think patients become doctors because someone cured them. I think sometimes they become doctors because someone stayed. Because someone showed them, over years of ordinary appointments, what it looks like to pay close attention to a person who is quietly carrying something.


This Is Not a Story About a Perfect Outcome

Her eyes still need looking after. She still struggles in difficult stretches. And is on medication. She still follows up.

But she built a life. She studied. And left home. She entered medicine. And every time she walks back into my clinic, I am reminded that the most important things in practice do not happen in the moments of diagnosis or surgery or crisis.

They happen in the reviews. The adjustments. The small, ordinary appointments where someone walks in and you already know who they are.

That is where medicine actually changes lives.

Last month, she graduated from medical school.


What Is Ocular GVHD?

Ocular graft-versus-host disease (ocular GVHD) is an eye condition that can develop after bone marrow or stem cell transplant. Donor immune cells may attack the tear glands and ocular surface, causing dryness, inflammation, and changes in visual comfort that persist long after the transplant itself has stabilised.

Symptoms can continue, fluctuate, or remain low-grade for years. Because of this, patients often benefit from long-term ophthalmic follow-up even when their systemic illness is well controlled and their measured vision remains good.

Symptoms of Ocular GVHD include:

Dry eyes, burning, irritation, fluctuating vision, redness, light sensitivity, watering, eye fatigue, difficulty reading or using screens for extended periods, and persistent ocular surface sensitivity that worsens with study, work, or environmental change.


How is Ocular GVHD classified?

Acute ocular GVHD develops during or soon after systemic acute GVHD and is characterized by sudden inflammation, redness, pain, tearing, photophobia, and conjunctival involvement.

Chronic ocular GVHD is a long-term immune-mediated disease that typically presents with persistent dry eye, burning, grittiness, fluctuating vision, meibomian gland dysfunction, and progressive ocular surface damage.

Acute-on-chronic ocular GVHD occurs when a patient with established chronic ocular GVHD experiences a sudden inflammatory flare, causing a rapid worsening of symptoms such as redness, pain, light sensitivity, and ocular surface inflammation on top of their baseline chronic dry eye disease.


When Should You See an Eye Specialist?

If you or your child has undergone a bone marrow or stem cell transplant and you notice persistent dryness, redness, fluctuating vision, burning, or discomfort — do not assume this is simply part of recovery.

The ocular surface can remain affected even after systemic disease feels far behind you. Early evaluation may preserve comfort, function, and long-term visual quality.

Known for her structured approach to vision risk assessment and progression analysis, Dr Shibal Bhartiya provides trusted second opinions for patients seeking clarity before major treatment decisions. Both, in person, and online.


This page is part of the Dry Eye Disease hub . Read about our full approach to GVHD, Dry Eyes and children’s eye care. Please also read Pediatric Eye Care hub

Here’s another heartening patient story: A young boy and his love for trucks


FAQs:

What is ocular GVHD?

Ocular GVHD is a complication that can develop after bone marrow or stem cell transplant. Donor immune cells affect the tear glands and eye surface, causing dryness, inflammation, and visual discomfort that may persist long after the main transplant illness stabilises.

What are the common symptoms?

Dry eyes, burning, fluctuating vision, redness, irritation, light sensitivity, watering, difficulty reading, and visual fatigue that worsens with screens or study.

Can ocular GVHD improve over time?

Yes. Many patients improve significantly, particularly with consistent treatment and close follow-up. Some continue to experience low-grade dryness or surface sensitivity for years. This does not mean the condition is untreatable — it means it requires sustained attention rather than a single course of treatment.

Can patients with ocular GVHD study, work, and live normally?

Many can, particularly when symptoms are identified early and managed consistently. The goal of treatment is not only to protect vision but to restore the quality of everyday life — reading, screens, study, and all the things that ordinary days are made of.

Why is long-term follow-up important?

Symptoms and underlying ocular surface health do not always change in parallel. A patient may feel stable and still have ongoing surface changes that benefit from monitoring. Regular review allows treatment to be adjusted before problems compound.

Does ocular GVHD affect children and young people differently?

The condition affects children and adolescents at a time when study load, screen use, and daily reading demands are high. Symptoms that an adult might manage around can significantly affect a young person’s academic performance and sense of normalcy. Recognising this early changes what the follow-up plan should look like.

About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google

Are steroid eye drops dangerous?

Steroid eye drops prescribed by a doctor are not dangerous. They become dangerous when used without a prescription, unsupervised, or for longer than directed, because they may increase your eye pressure. This puts you at risk for steroid induced glaucoma. But when your doctor prescribes them, the benefit — stopping inflammation, saving vision — outweighs the risk. Avoiding a necessary prescription is where real harm begins, explains Dr Shibal Bhartiya.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.

Steroids in the Eye: When Fear of the Drop Does More Damage

She was a psychiatrist. A trained physician. She understood pharmacology, and she had read about intraocular pressure and steroid response. So when her ophthalmologist prescribed steroid eye drops after an adenoviral conjunctivitis, she quietly decided not to use them.

Three months later, she sat in front of me. A psychiatrist — a trained physician — spent three months losing vision because she was afraid to use a prescribed drop. Here is what that case teaches every patient.

Her vision had dropped to 6/18 in both eyes. Her corneas were covered in superficial punctate keratitis — so dense and widespread it looked almost like numular keratitis. What began as a straightforward viral conjunctivitis had become a prolonged, damaging inflammatory response, because her immune system was never asked to stand down.

She had never had her eye pressure checked, and was not a known steroid responder. She had simply been afraid of a word.

Within three to four days of starting the prescribed drops, she began to improve. Her vision normalised in two weeks. Three months of avoidable suffering — from one decision to skip a prescription. Her pressures remained well within normal limits.

Why the Fear Exists — and the Risk

Steroids raise eye pressure in susceptible individuals. This is true. In long-term, unsupervised use, the kind that happens when people buy steroid drops over the counter, this risk is real and serious. Steroid Induced Glaucoma can cause irreversible vision loss.

But this is not the situation your doctor creates when they hand you a prescription. She will check your eye pressures before starting eye drops, and monitor it through the duration of therapy.

A doctor prescribing steroid drops accounts for:

  • The specific diagnosis — inflammation, allergy, or a post-viral immune response
  • The right steroid molecule and strength for that condition
  • A taper plan, not an open-ended course
  • Pressure monitoring if the course extends beyond the short term

The risk of not using the drops, in the right condition, is often far greater than any monitored, time-limited course.

Important

In India, steroid eye drops can be purchased without a prescription. This does not make it safe. Unsupervised, over-the-counter steroid use is the primary source of steroid-related eye damage: not prescribed, monitored courses. The two situations carry entirely different risk profiles.

To know more about glaucoma, risks and symptoms, you may want to listen to this conversation

VKC in Children: Where Hesitation Costs Sight

Parents of children with vernal keratoconjunctivitis (VKC) frequently arrive distressed at the idea of steroids for their child. The concern is understandable. It is also, when correctly informed, less alarming than the disease itself.

Fluorometholone and loteprednol are approved for children as young as one year in the United States. These are not aggressive systemic steroids. They are targeted molecules with well-established paediatric safety records, prescribed precisely because the risks of the disease exceed the risks of the treatment.

Giant papillary conjunctivitis does not respond to antiallergic drops alone. Corneal shields (or shield ulcers) — the plaques that form in severe VKC — do not respond to cold compresses, and mild anti allergies. The window for preventing permanent corneal damage is not infinite.

In these cases, the right medicine at the right time, under supervision, is the difference between a child who sees normally and one who does not.

Steroid Eye Drops at a Glance

Molecules, indications, risk by scenario, and cost of avoidance — combined reference

Steroid / ScenarioCommon UseApproved AgeSupervised RiskUnsupervised / OTC RiskCost of Avoidance
Steroid Molecules
Prednisolone acetateSevere inflammation, post-surgical, uveitisAdults (caution in children)Moderate
Higher IOP risk; needs monitoring
High
Glaucoma, cataract risk
Corneal scarring, vision loss
Fluorometholone (FML)Allergic conjunctivitis, VKC, mild-moderate inflammation≥ 2 years (US approval)Lower
Reduced IOP penetration
Moderate
Still causes pressure rise if prolonged
Persistent giant papillae, corneal shield
LoteprednolVKC, seasonal allergy, post-surgical≥ 1 year (US approval)Low
Metabolised locally; lowest IOP burden
Moderate
Risk increases with duration
Persistent severe allergy, corneal damage
DexamethasoneSevere ocular inflammation, post-op, uveitisAdults; children under specialist careModerate–High
Strong molecule; close monitoring needed
Very High
Rapid IOP rise possible
Irreversible optic nerve damage if pressure unchecked
Clinical Scenarios
Post-viral keratitis (adenoviral)Subepithelial infiltrates, SPK, vision dropAll agesLow–Moderate
Short course, tapered
High
Prolonged use → pressure crisis
Persistent SPKs, 6/18 or worse vision — as seen in case above
VKC (children)Giant papillae, shield ulcer risk, corneal involvementAs young as 1 year with appropriate moleculeLow
With loteprednol / FML and monitoring
High
Inappropriate molecule + no monitoring
Corneal shield ulcer, permanent visual impairment
Giant papillary conjunctivitisSevere allergic response, contact lens–relatedAdults and older childrenLow–Moderate
Under supervision
ModerateNo response to antiallergics alone; chronic discomfort, corneal involvement
Use Pattern Risk
Prescribed short course (7–14 days, tapered)Any indicated conditionLowN/A — by definition supervisedAvoidance causes disease progression
OTC self-medication, IndiaOften misused for red eye, irritationN/AVery High
No diagnosis, no taper, no monitoring
Steroid-induced glaucoma, cataract — often irreversible

What You Should — and Should Not — Do

Use steroid eye drops when your doctor prescribes them. Follow the taper exactly. Do not stop abruptly. Have your pressure checked if your doctor asks. Do not extend the course on your own judgment.

Do not buy steroid eye drops from a pharmacy without a prescription. In India, this is possible. It is also the origin of most steroid-related eye complications seen in clinical practice — not prescribed, monitored use.

Frequently Asked Questions

Can steroid eye drops damage my eyes?

Steroid eye drops used without medical supervision, and for longer than prescribed, can raise eye pressure, cause cataracts, and increase infection risk. Prescribed, monitored courses carry a very different risk profile. The damage in most cases comes from unsupervised, over-the-counter use — not from following a doctor’s prescription.

Why did my doctor prescribe steroid drops after conjunctivitis?

After viral conjunctivitis — particularly adenoviral — the eye can mount a prolonged inflammatory response even after the infection clears. Steroid drops are prescribed to control this immune response and protect the cornea. Skipping them does not protect you. It leaves the inflammation unchecked.

Are steroid eye drops safe for children with VKC?

Specific steroid molecules — fluorometholone, loteprednol — are approved for use in young children and have an established paediatric safety record. In vernal keratoconjunctivitis, the risk of corneal damage from untreated disease is often greater than the risk from a supervised steroid course.

Can I buy steroid eye drops without a prescription in India?

Unscrupulous pharmacies in India dispense them without a prescription. This does not mean it is safe. Unsupervised steroid use is the primary cause of steroid-related eye complications. Always use them under a doctor’s direction.

What is a steroid responder?

Some individuals — roughly 5% of the population — show a significant rise in eye pressure in response to steroid drops. This is a genetic predisposition. It does not mean everyone should avoid steroids; it means a doctor prescribing steroids should check your pressure during use, particularly if the course extends beyond two weeks.

About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google

Is Your Screen Giving You Dry Eyes?

Yes. Prolonged screen use reduces your blink rate by up to 60%, which destabilises the tear film and causes dry eye disease. Symptoms include burning, grittiness, blurred vision, and watering eyes. If you spend more than four hours a day on screens, you are at significant risk.

You blink about 15 times a minute when you are not looking at a screen. Put a phone or laptop in front of you, and that number drops to five or six. Each blink spreads a fresh layer of tears across your eye surface. Fewer blinks mean faster tear evaporation. Faster evaporation means dry eye.

This is not a minor inconvenience. It is a disease process. And in Gurgaon, where long office hours, air conditioning, and pollution compound the problem, it is one of the most common reasons patients come to see me.


What Exactly Happens to Your Eyes on a Screen

Your tears have three layers: an oily outer layer, a watery middle layer, and a mucus base. The oily layer, produced by the meibomian glands along your eyelid margins, is the most important for stability. Every time you blink, these glands express a fresh film of oil that slows evaporation.

When you stare at a screen, two things happen at once. Your blink rate falls sharply. And you tend to hold your eyes open wider, increasing the surface area exposed to air. The tear film breaks up faster than it can be replaced. The result is what we call evaporative dry eye disease — the most common form.

Research involving over 1,300 students found that nearly one in three people who use screens for six or more hours daily develop clinically diagnosable dry eye disease — not just discomfort, but measurable damage to the tear film and ocular surface.


Symptoms: What Screen-Related Dry Eye Feels Like

Patients describe it differently. Some say their eyes feel gritty, as if there is sand under the lid. Others notice burning, redness, or a heaviness at the end of the day. Many come in saying their eyes water constantly — which seems contradictory, but is classic dry eye. The surface dries, the eye panics, and the lacrimal gland floods it with reflex tears that do not have the right composition to actually help.

Some people ask: Why do my eyes feel dry after using my phone?” “Can screen time cause blurry vision?” “My eyes burn after computer work.” “Why do my eyes feel tired even after sleeping?” “How do screens affect blinking?” “Why does vision fluctuate during screen use?”

The answer to all these questions is often dryness of eyes.

Other symptoms include:

  • Blurred vision that clears when you blink
  • Sensitivity to light, especially in air-conditioned rooms
  • Eye fatigue after reading or driving
  • Difficulty wearing contact lenses

Studies show that burning, dryness, and eye pain are among the most frequently reported symptoms in people who spend extended time in front of screens, with many experiencing symptoms that persist well beyond working hours.

If your symptoms are worse by evening, worse in AC environments, and worse in dry weather — screen-related dry eye is the most likely cause.


Why Gurgaon Makes It Worse

Most cities have one environmental aggravator. Gurgaon has several operating simultaneously.

The air quality in and around Gurugram is consistently poor. Particulate matter and pollutants deposit on the ocular surface, triggering inflammation that compromises the tear film even before you open your laptop. Add to this the aggressive air conditioning in most offices and malls — which pulls moisture from the air and from your eyes — and a working day in Gurgaon is a sustained assault on tear film stability.

Then add the screen.

Patients who work eight-hour days in air-conditioned offices with poor air quality and high screen time are in a perfect storm. I see this combination daily. It is not unusual for someone in their late twenties or early thirties to present with tear film parameters more consistent with a 50-year-old.

You may want to read this article, that I wrote for the Times of India.

https://timesofindia.indiatimes.com/india/can-extended-screen-time-damage-our-eyesight-a-doctor-weighs-in/articleshow/83749175.cms


The 20-20-20 Rule: Useful, But Not Enough

You have likely heard of the 20-20-20 rule: every 20 minutes, look at something 20 feet away for 20 seconds. It is a reasonable starting point. It prompts you to blink more and reduces accommodative stress on the focusing muscles.

But for established dry eye disease, it is not treatment. It is habit maintenance. If your meibomian glands are already dysfunctional — blocked, inflamed, or atrophied — no amount of screen breaks will restore their function without medical intervention.

Think of it this way: telling someone with a broken leg to take shorter walks is kind advice. But the leg still needs to be set.


When to See a Specialist

Many patients manage dry eye with over-the-counter lubricating drops for months or years before seeking help. This is understandable, but it often means the underlying cause — meibomian gland dysfunction, ocular surface inflammation, or tear film instability — progresses untreated.

See a dry eye specialist if:

  • Lubricating drops help briefly but symptoms return within an hour
  • You wake up with eye discomfort or sticky lids
  • Your vision fluctuates through the day
  • Symptoms are affecting your ability to work or drive
  • You have been using drops for more than three months without improvement

A proper dry eye assessment takes around 30 minutes and includes tear film measurement, meibomian gland evaluation, and ocular surface staining. It gives you a diagnosis, not just a description of your symptoms.

Seeing Another Specialist About Dry Eye?

A second opinion is always reasonable when symptoms persist despite treatment. Dry eye is frequently undertreated because it is underdiagnosed — many patients are managed on lubricating drops alone without a full tear film assessment or meibomian gland evaluation.

If you have been told your eyes are “just dry” without a formal diagnosis, or if your current treatment is not giving you lasting relief, a structured review can clarify what is actually driving your symptoms and whether your treatment matches the cause.

Dr Shibal Bhartiya offers dry eye second opinion consultations at Marengo Asia Hospitals, Sector 56, Gurugram. Bring your current drop regimen, any previous reports, and a list of your symptoms and their pattern through the day.

📞 +91 88826 38735


What Treatment Actually Looks Like

Treatment depends on what is driving the dry eye. Screen-related dry eye is almost always evaporative, which means meibomian gland dysfunction is at the centre of it.

The approach I use combines:

Warm compresses and lid hygiene — daily, applied consistently for at least four weeks before judging results. This softens blocked meibomian secretions and restores gland function over time.

Preservative-free lubricating drops — frequency matters. If you are using drops twice a day but your tear film breaks up every three seconds, the maths does not work. Most patients need drops every one to two hours initially.

Anti-inflammatory treatment — in moderate to severe cases, a short course of topical anti-inflammatory medication reduces the surface inflammation that perpetuates the cycle.

Environmental modification — a humidifier at your workstation, positioning your screen below eye level (to reduce exposed surface area), and reducing direct airflow from AC vents toward your face.

In cases with significant meibomian gland atrophy, in-office procedures that express and heat the glands directly can restore function that drops and compresses alone cannot achieve.


Screen Dry Eye vs Normal Eye Tiredness: How to Tell the Difference

Normal Eye TirednessScreen-Related Dry Eye Disease
When it startsEnd of a long dayWithin hours of screen use, most days
How it feelsHeavy, sleepy eyesBurning, gritty, sandy, or stinging
VisionSlightly blurred when tiredFluctuates and clears on blinking
After restFully resolved by morningPersists or returns quickly next day
WateringRareCommon — reflex tearing
AC sensitivityMildNoticeably worse in air-conditioned rooms
DropsNot neededTemporary relief only
What it meansRest is enoughTear film is compromised — see a specialist

A Note on Glaucoma Eye Drops and Dry Eye

If you have glaucoma and use topical eye drops, be aware that most preserved antiglaucoma drops — particularly those containing benzalkonium chloride — can cause and worsen dry eye disease. This is a combination I see frequently in my practice. Switching to preservative-free formulations, where possible, makes a significant difference. If you use glaucoma drops and also experience dry eye symptoms, bring both to your specialist’s attention.


The Bottom Line

Your screen is not going to damage your eyes permanently if you act on the symptoms early. Dry eye from digital device use is common, well understood, and treatable. What makes it worse is ignoring it, self-managing with inadequate treatment, or assuming it will resolve on its own.

Also remember:

  • Dry eyes becoming more common in children and younger adults.
  • Menopause increases dryness of eyes.
  • Seeing clearly is not always the same as seeing comfortably.
  • Screen-related symptoms may reflect tear film instability rather than a glasses problem.
  • More screen time does not always mean more damage, but it can increase symptom burden.

If your eyes are telling you something by the end of every working day, listen.

Here are some tips of preventing dry eye, especially in the summer


FAQs

Can screen time actually cause dry eye disease, or just discomfort?

It can cause dry eye disease — not just temporary discomfort. Prolonged screen use reduces blink rate significantly, which destabilises the tear film and triggers the inflammatory cycle underlying dry eye disease. In people who spend six or more hours daily on screens, clinically diagnosable dry eye is common, not just eye strain. The difference matters because discomfort resolves with rest. Dry eye disease does not.


How many hours of screen time is too much for eye health?

There is no universally safe threshold, but research consistently shows that symptoms rise sharply beyond four hours of continuous screen use per day. What matters as much as total hours is whether you take breaks, blink consciously, and manage your environment. Eight hours broken into segments with proper hygiene is less damaging than four hours of uninterrupted staring in a cold, air-conditioned room.


Why do my eyes water if they are dry?

This is one of the most common questions I hear. When the eye surface dries and becomes irritated, the lacrimal gland responds with a flood of reflex tears. These tears are watery and thin — they do not have the oily, stable composition of normal tears. They wash across the surface and spill over the lid margin, but they do not actually fix the dryness. Watering eyes and dry eye disease are not opposites. They frequently occur together.


Do blue light glasses help with dry eye?

Blue light glasses may reduce some visual discomfort and improve sleep if worn in the evening, but they do not treat dry eye disease. Dry eye from screens is caused by reduced blinking and tear film instability — not by the wavelength of light reaching your eyes. If your main symptom is dryness, burning, or grittiness, blue light glasses will not address the underlying problem.

Here’s some information about blue light blocking glasses, in hindi.


Can dry eye from screens be permanently cured?

For most patients, dry eye disease is a chronic condition that is managed rather than cured. However, many people achieve complete symptom control with the right combination of treatment and habit change. The goal is to restore meibomian gland function, stabilise the tear film, and reduce environmental triggers. With consistent treatment, the majority of patients with screen-related dry eye see significant, sustained improvement.


When should I stop using over-the-counter drops and see a specialist?

Stop managing it yourself if drops give you less than an hour of relief, if symptoms are affecting your ability to work or drive, if you wake up with sticky or uncomfortable eyes, or if you have been using drops for more than three months without real improvement. Over-the-counter drops manage symptoms. They do not treat the underlying cause. A 30-minute specialist assessment will tell you what is actually driving the dry eye — and what will actually fix it.


About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google


Read More

Basics of Dry Eye

Dry Eye Second Opinion

Dry Eye: A Chronic Disease

Why Do Women Get Dry Eye More Often?

Menopause and Dry Eye

Dry Eyes: Natural Remedies

Dry Eyes: Tips to Soothe Sore Eyes

Why Dry Eye Is Worse in Air Conditioning and on Flights

Why Vision Becomes Blurred After Reading or Screen Use

Screen Fatigue

Why Your Eyes Water Constantly

Omega-3 and Dry Eye

Why Are Your Dry Eye Drops Not Working

Autologous Serum Eye Drops for Severe Dry Eye

Why Are My Eyes Red?

Red eyes can happen due to dryness, allergies, infection, eye strain, inflammation, or even hidden eye conditions like glaucoma. Persistent redness, especially with pain, blurred vision, light sensitivity, or discharge, should not be ignored and may need an eye specialist evaluation.

Red eyes are almost always caused by dilated blood vessels on the surface of the eye — and the cause ranges from trivial to sight-threatening. Allergy, dry eye, and screen fatigue account for the vast majority. But a red eye with pain, reduced vision, or photosensitivity is a different matter entirely — and can mean acute glaucoma, corneal ulcer, or uveitis, all of which require same-day assessment.


What makes the eye red?

The white of the eye (sclera) is covered by a transparent membrane called the conjunctiva, which contains a network of tiny blood vessels. These vessels dilate — becoming visible — in response to inflammation, infection, irritation, trauma, or pressure change. Redness is a non-specific sign; the pattern, location, and accompanying symptoms narrow the diagnosis.


Why Are My Eyes Red? Causes, Emergency Signs, and What Needs Treatment

1. Conjunctivitis — infective The most common cause worldwide. Bacterial conjunctivitis produces a red eye with mucopurulent (yellow-green) discharge, lids stuck together in the morning. Viral conjunctivitis — usually adenovirus — produces a watery, highly contagious red eye, often starting in one eye then spreading. Both are usually self-limiting but require hygiene measures and sometimes antibiotic drops for bacterial forms.

2. Allergic conjunctivitis Bilateral redness with intense itching — the hallmark symptom. Watering, lid swelling, and chemosis (conjunctival swelling). Seasonal in pollen allergy, perennial in dust mite or pet allergy. Worse in Gurgaon during spring and high-pollution periods. Does not cause vision loss. Antihistamine drops and mast cell stabilisers are effective.

3. Dry eye disease Chronic, low-grade bilateral redness — dull rather than vivid. Associated with burning, foreign body sensation, and fluctuating vision. Worse in air conditioning, on screens, and in the evening. The most underdiagnosed cause of persistent red eyes in urban working adults.

4. Subconjunctival haemorrhage A dramatic-looking, painless, bright red patch on the white of the eye — caused by rupture of a tiny blood vessel. Alarming in appearance, almost always benign. Caused by coughing, straining, rubbing, or occurring spontaneously. Resolves in 2–3 weeks without treatment. Recurrent or bilateral subconjunctival haemorrhage warrants blood pressure and bleeding disorder assessment.

5. Blepharitis Chronic eyelid margin inflammation causes redness along the lid margins, spreading to the adjacent conjunctiva. Associated with morning crusting, burning, and dry eye. Long-term condition requiring ongoing lid hygiene rather than repeated antibiotic courses.

6. Contact lens overuse Extended or overnight contact lens wear reduces oxygen delivery to the cornea, inducing limbal vessel ingrowth and redness. Overwear also significantly increases infection risk — contact lens-related bacterial keratitis is a sight-threatening emergency. Any red, painful eye in a contact lens wearer should be assessed the same day.

7. Episcleritis A localised, sectoral redness — a wedge or patch of bright red on one area of the eye. Usually painless or mildly tender. Self-limiting in most cases. Associated with systemic inflammatory conditions (rheumatoid arthritis, IBD, lupus) in a minority. Distinguishable from scleritis, which is deeply painful and vision-threatening.


Warning signs: red eye emergencies

Acute angle-closure glaucoma Severe, sudden eye pain with redness, nausea, vomiting, blurred vision, and halos around lights. The eye is rock-hard. The pupil is mid-dilated and non-reactive. IOP can reach 50–70 mmHg. This is a glaucoma emergency — permanent vision loss occurs within hours. Go immediately to an eye emergency unit.

Corneal ulcer A painful red eye with photosensitivity, discharge, and a white spot on the cornea. Common in contact lens wearers. Caused by bacteria (Pseudomonas most aggressively), fungi, or Acanthamoeba. Requires urgent culture and intensive antibiotic therapy. Delay causes corneal scarring and permanent visual impairment.

Uveitis (iritis) Redness concentrated around the cornea (ciliary flush) — not diffuse. Associated with deep, aching eye pain, photosensitivity, and a small or irregular pupil. Vision may be reduced. Uveitis can be associated with systemic conditions — ankylosing spondylitis, sarcoidosis, TB, juvenile arthritis. Requires urgent slit-lamp examination and steroid treatment. Untreated uveitis causes cataracts, glaucoma, and permanent vision loss.

Scleritis Deep, boring eye pain — often severe enough to wake from sleep — with a violaceous (deep red-purple) hue to the sclera. Associated with systemic vasculitis, rheumatoid arthritis, and Wegener’s granulomatosis. Can cause scleral thinning and globe perforation if untreated. Requires systemic anti-inflammatory treatment.

Endophthalmitis Post-surgical or post-injection intraocular infection. Acute onset of red eye, pain, and rapid vision loss following recent eye surgery or intravitreal injection. A surgical emergency — vitrectomy and intravitreal antibiotics within hours.


Emergency Signs, and What Needs Treatment

PatternMost Likely CauseUrgency
Both eyes red, itching, seasonalAllergic conjunctivitisRoutine
Red + watery discharge, started in one eyeViral conjunctivitisRoutine — hygiene
Red + yellow-green discharge, lids stuckBacterial conjunctivitisRoutine — antibiotic drops
Chronic, dull redness, dry burning sensationDry eye / blepharitisRoutine
Bright red patch, no pain, no vision changeSubconjunctival haemorrhageRoutine — reassurance
Sectoral redness, mild tendernessEpiscleritisRoutine
Red + pain + photosensitivity + ciliary flushUveitisUrgent — same day
Red + pain + white spot on corneaCorneal ulcerUrgent — same day
Red + severe pain + nausea + halos + blurred visionAcute angle-closure glaucomaEmergency — now
Red + pain + deep purple hue + wakes from sleepScleritisUrgent — same day
Red + pain + vision loss after eye surgeryEndophthalmitisEmergency — now

What We often miss

Uveitis is frequently treated as conjunctivitis — antibiotic drops prescribed for a red eye without slit-lamp examination. Conjunctivitis does not cause photosensitivity, does not cause ciliary flush, and does not cause a small irregular pupil. Any red eye with these features requires a slit lamp.

Dry eye as a cause of chronic redness is underdiagnosed. Patients receive repeated courses of antibiotic and anti-allergy drops that temporarily suppress symptoms without addressing the underlying tear film pathology.

Acute angle-closure glaucoma is missed when patients present to a general physician with nausea and headache — and the eye is not examined. Any adult with sudden severe headache, nausea, and a red eye should have IOP measured immediately.


Frequently asked questions

Why are my eyes red when I wake up?

Morning redness suggests nocturnal lagophthalmos (incomplete eye closure during sleep), blepharitis, or dry eye with overnight surface exposure. Contact lens wearers sleeping in lenses is another common cause.

Can screen time cause red eyes?

Yes — reduced blink rate during screen use causes tear film instability, surface dryness, and conjunctival vessel dilation. The 20-20-20 rule and conscious blinking reduce this significantly.

Why is only one eye red?

Unilateral redness suggests a localised cause — corneal foreign body, subconjunctival haemorrhage, episcleritis, uveitis, or early conjunctivitis. Bilateral causes (allergy, dry eye) usually affect both eyes.

Can red eyes be a sign of something serious?

Yes — uveitis, corneal ulcer, scleritis, and acute glaucoma all present with red eyes and are serious. The accompanying symptoms — pain, photosensitivity, vision loss — distinguish these from benign causes.

Can I use eye drops from a pharmacy for red eyes?

Vasoconstrictor drops (those that “get the red out”) mask redness without treating the cause and cause rebound redness with prolonged use. They should not be used regularly. Lubricant drops for dry eye are appropriate. Antihistamine drops for allergy are appropriate. For anything else — see a doctor.

When is a red eye an emergency?

Seek same-day care for: red eye with pain, red eye with reduced vision, red eye with photosensitivity, red eye after eye surgery, red eye with nausea and halos around lights, or red eye in a contact lens wearer.


A red eye is not always simple. If yours is painful, photosensitive, or reducing your vision — do not wait for it to clear. Dr Shibal Bhartiya offers same-day emergency eye assessments in Gurgaon.

📞 +91 88826 38735 | www.drshibalbhartiya.com Upload previous eye reports for a pre-consultation review.


About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google